<DOC>
	<DOC>NCT01425697</DOC>
	<brief_summary>The purpose of the study is to see if using 2% Chlorhexidine cloths will reduce surgical site infections in patients having elective cardiac surgery.</brief_summary>
	<brief_title>Eliminate Risk of Cardiac Surgical Site Events</brief_title>
	<detailed_description>A randomized, prospective study utilizing 2% Chlorhexidine cloths to evaluate the product's effectiveness in reducing surgical site infections in elective cardiothoracic surgery patients. Sage 2% chlorhexidine cloths are approved by the Food and Drug Administration (FDA) for preparation of skin prior to surgery. The study hypothesis is that the preoperative surgical preparation with 2% chlorhexidine cloths, which leaves chlorhexidine on the skin, will reduce surgical site infections by 50% as compared to current standard procedure.</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Surgical Wound Infection</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<criteria>Elective cardiothoracic surgery patients &gt; 18 years old. Informed consent obtained Any current known allergies to chlorhexidine gluconate Currently taking any oral or topical antibiotics Any active skin rashes or breaks in the skin on areas to be treated with chlorhexidine gluconate A current active skin disease or inflammatory skin condition, known preexisting skin infection, including contact dermatitis that is currently being treated with an antibiotic Any medical condition or use of any medications that in the opinion of the Principal Investigator preclude participation. Unwillingness or failure to fulfill requirements of the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Adult Cardiac surgery</keyword>
	<keyword>Surgery site infections</keyword>
</DOC>